ADVERTISEMENT
ADVERTISEMENT

Inhibrx Adopts DNASTAR Lasergene Software

Inhibrx has entered into an agreement supoorting an organization-wide site lcience of DNASTAR Lasergene software.

DNASTAR

John Trimmer Ph.D., the Reseach Director of Inhibrx commented, "After using Lasergene software in-house to meet our day to day sequence analysis needs, it became clear that a long-term, company-wide site licence of the software makes sense for our organization. We have found the software to be easy to use and powerful, and DNASTAR's technical support has been very responsive and on point. By committing to this licence for multiple years, our scientists can count on a consistent, strong platform being available to them through their research projects. We look forward to using Lasergene on an increasing basis as we continue to grow our business."

Tom Schwei, Vice President and General Manager of DNASTAR, stated, "We appreciate the confidence shown by Inhibrx in making this milti-year commitment to using our software as an integral part of their research and business. As a leading-edge firm in developing fit-for-function biotherapeutics, Inhibrx represents...

Financil terms of the arrangement were not disclosed.

Interested in reading more?

The Scientist ARCHIVES

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
ADVERTISEMENT